Intracytoplasmic cytokine levels and neutrophil functions in early clinical stage of type 1 diabetes

Diabetes Research and Clinical Practice

Volumn 79, Issue 1, 2008, Pages 31-36

  Bilgic, S ^a   Aktas, E ^a   Salman, F ^a   Ersahin, G ^a   Erten, G ^a   Yilmaz, M T ^b   Deniz, G ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cytokines; Oxidative burst; Phagocytosis; Type 1 diabetes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLUCOSE; GLUTAMATE DECARBOXYLASE ANTIBODY; HEMOGLOBIN A1C; INTERLEUKIN 10; INTERLEUKIN 2; PANCREAS ISLET CELL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DESTRUCTION; CELL FUNCTION; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE DURATION; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; NEUTROPHIL; PANCREAS ISLET BETA CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; RESPIRATORY BURST; TH1 CELL; TH2 CELL;

ADULT; ANTIGENS, CD; AUTOANTIBODIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; CYTOPLASM; DIABETES MELLITUS, TYPE 1; HUMANS; MIDDLE AGED; NEUTROPHILS; PHAGOCYTOSIS; REFERENCE VALUES; RESPIRATORY BURST;

EID: 37549038273     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.06.011     Document Type: Article

References (38)

1. Bresson D., and von Herrath M. Mechanism underlying type 1 diabetes. Drug Discov. Today: Dis. Mech. 1 3 (2004) 321-327
2. Katz J., Benoist C., and Mathis D. Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur. J. Immunol. 23 (1993) 3358-3360
3. Doyle C., and Strominger J.L. Interaction of CD4 and Class II MHC molecules mediates cell adhesion. Nature 330 (1987) 256-259
4. Itoh N., Hanafusa T., and Miyazaki A. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J. Clin. Invest. 92 (1993) 2313-2322
5. Honen J., Surcel H.M., and Küür M.L. Abnormalities with in CD4 and CD8 T lymphocyte subsets in type 1 diabetes. Clin. Exp. Immunol. 85 (1991) 278-281
6. De Maria R., and Testi R. Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity. Immunol. Today 19 (1998) 121-125
7. Romagnani S. The Th1/Th2 paradigm. Immunol. Today 18 (1997) 263-266
8. + T cells. J. Immunol. 158 (1997) 1085-1094
9. Romagnani S. Human Th1 and Th2 subsets. Doubt no more. Immunol. Today 12 (1991) 256-257
10. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16 (1995) 34-38
11. Kroemer G., Andreu J.L., Gonzalo J.A., Gutierrez-Ramos J.C., and Martinez C. Interleukin-2 autotolerance and autoimmunity. Adv. Immunol. 50 (1991) 147-235
12. Woda B.A., and Biron C.A. Natural killer cell number and function in spontaneously diabetic BB/W rat. J. Immunol. 136 (1986) 513-516
13. Goldstein I.M. In: Synderman R. (Ed). Inflammation, Basic Principles and Clinical Correlates (1992), Raven Press, New York
14. Hurst J.K., and Barrette Jr. W.C. Leukocytic oxygen activation and microbicidal oxidative toxins. Crit. Rev. Biochem. Mol. Biol. 24 (1989) 271-328
15. Lehrer R.I., and Ganz T. Antimicrobial polypeptides of human neutrophils. Blood 76 (1990) 2169-2181
16. Smith J.A., and Weidemann M.J. Further characterization of the neutrophil oxidative burst by flow cytometry. J. Immunol. Meth. 162 (1993) 261-268
17. Rothe G., Oser A., and Valet G. Dihydrorhodamine 123: a new flow cytometric indicator for respiratory burst activity in neutrophil granulocytes. Naturwissenschaften 75 (1988) 354-355
18. Rabinson J.P., and Badcock F.G. Phagocyte Function (1995), Wiley-Liss Press, New York
19. Marhoffer W., Stein M., Schleinkofer L., and Federlin K. Evidence of ex vivo and in vitro impaired neutrophil oxidative burst and phagocytic capacity in type 1 diabetes mellitus. Diabetes Res. Clin. Pract. 19 (1993) 183-188
20. Marhoffer W., Stein M., Maser E., and Federlin K. Reduced phagocytic capacity of circulating granulocytes in diabetes mellitus. Immun. Infekt. 20 (1992) 10-12
21. Tater D., Tepaut B., Bercovici J.P., and Youinou P. Polymorphonuclear cell derangements in type 1 diabetes. Horm. Metab. Res. 19 (1987) 642-647
22. Gin H., Brottier E., and Aubertin J. Influence of glycaemic normalisation by an artificial pancreas on phagocytic and bactericidal functions of granulocytes in insulin dependent diabetic patients. J. Clin. Pathol. 37 (1984) 1029-1031
23. Mazade M.A., and Edwards M.S. Impairment of type III group B streptococcus-stimulated superoxide production and opsonophagocytosis by neutrophils in diabetes. Mol. Genet. Metab. 73 (2001) 259-267
24. Walrand S., Guillet C., Gachon P., Giraudet C., Rousset P., Vasson M.P., et al. Insulin regulates protein synthesis rate in leukocytes from young and elderly healthy humans. Clin. Nutr. 24 (2005) 1089-1098
25. Thomson G.A., Fisher B.M., Gemmell C.G., MacCuish A.C., and Gallacher S.J. Attenuated neutrophil respiratory burst following acute hypoglycaemia in diabetic patients and normal subjects. Acta Diabetol. 34 (1997) 253-256
26. Marée A.F., Komba M., Dyck C., Labecki M., Finegood D.T., and Edelstein-Keshet L. Quantifying macrophage defects in type 1 diabetes. J. Theor. Biol. 4 (2005) 533-551
27. De Block C.E., De Leeuw I.H., Rooman R.P., Winnock F., Du Caju M.V., and Van Gaal L.F. Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and HLA DQA1*0501-DQB1*0301 haplotype in type 1 diabetes mellitus. Belgian Diabetes Registry. Diabet. Med. 17 (2000) 618-622
28. Sera Y., Kawasaki E., Abiru N., Ozaki M., Abe T., Takino H., et al. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening. J. Autoimmun. 13 (1999) 257-265
29. Kikutani H., and Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51 (1992) 285-322
30. Shehadeh N.N., LaRosa F., and Lafferty K.J. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6 (1993) 291-300
31. von Herrath M.G., and Oldstone M.B. Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus. J. Exp. Med. 185 (1997) 531-539
32. Nicoletti F., Zaccone P., Di Marco R., Lunetta M., Magro G., Grasso S., et al. Prevention of spontaneous autoimmune diabetes in diabetes-prone BB rats by prophylactic treatment with antirat interferon-gamma antibody. Endocrinology 138 (1997) 281-288
33. Yoon J.W., Jun H.S., and Santamaria P. Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells. Autoimmunity 27 (1998) 109-122
34. Katz J.D., Benoist C., and Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 268 (1995) 1185-1188
35. Stewart T.A., Hultgren B., Huang X., Pitts-Meek S., Hully J., and MacLachlan N.J. Induction of type I diabetes by interferon-alpha in transgenic mice. Science 260 (1993) 1942-1946
36. Mueller R., Krahl T., and Sarvetnick N. Pancreatic expression of IL-4 abrogates insulitis and autoimmune diabetes in non-obese diabetic (NOD) mice. J. Exp. Med. 184 (1996) 1093-1099
37. Pilström B., Björk L., and Böhme J. Monokine-producing cells predominate in the recruitment phase of NOD insulitis while cells producing Th1-type cytokines characterize the effector phase. J. Autoimmun. 10 (1997) 147-155
38. Kjersem H., Hilsted J., Madsbad S., Wandall J.H., Johansen K.S., and Borregaard N. Polymorphonuclear leukocyte dysfunction during short term metabolic changes from normo- to hyperglycemia in type 1 (insulin dependent) diabetic patient. Infection 16 (1988) 215-221